Skip to main content
Category

Community Events

MIND Matters | Quarterly Newsletter | Winter 2023

By Clinical Trials, Commentary, Community Events, COVID-19, In the News, Longitudinal Cohort, Participants, UCI MIND

Message from the Director Dear Friends of UCI MIND, Advances in the field of Alzheimer’s disease (AD) research and the contributions of UCI MIND investigators remain tremendously exciting. Two new drugs have been approved by the FDA (page 3). These approvals are believed by many to represent the dawn of a new age in AD research and treatment. Both drugs received accelerated approval and we await a decision from the FDA about “full approval” for lecanemab. If received, full approval could cause the Centers for Medicare and Medicaid Services to revisit their previous coverage decision about anti-amyloid antibody therapies. These…

The post MIND Matters | Quarterly Newsletter | Winter 2023 appeared first on UCI MIND.

Read More

MIND Matters | Quarterly Newsletter | Fall 2022

By Clinical Trials, Commentary, Community Events, COVID-19, In the News, Longitudinal Cohort, Participants, UCI MIND

Message from the Director Dear Friends of UCI MIND, As the fall MIND Matters newsletter goes to print, many of us are preparing to travel to San Francisco for the annual Clinical Trials in Alzheimer’s Disease (CTAD) meeting, where we will hear important results from recently completed Phase 3 clinical trials of potential new therapies for Alzheimer’s disease (AD). This includes trials of lecanemab (page 1) as well as other treatments. The topline results for lecanemab announced by the trial sponsors are exciting and suggest that lecanemab may slow the progression of AD. The availability of treatments to slow the…

The post MIND Matters | Quarterly Newsletter | Fall 2022 appeared first on UCI MIND.

Read More

MIND Matters | Quarterly Newsletter | Summer 2022

By Clinical Trials, Commentary, Community Events, COVID-19, In the News, Longitudinal Cohort, Participants, UCI MIND

Message from the Director Dear Friends of UCI MIND, We hope that you had a summer full of sun, fun, and good health. As you can see in this issue of MIND Matters, it has been a busy summer here at UCI MIND. Our investigators played a prominent role at the annual Alzheimer’s Association International Conference (AAIC), a focus of this issue (p 1, 3, 6, and 7). We’re very proud of our own Maria Corrada, ScD, who played a role in planning this important meeting (p 1 and 7), as well as the many researchers who presented their work….

The post MIND Matters | Quarterly Newsletter | Summer 2022 appeared first on UCI MIND.

Read More

2022 Buddy Walk

By Commentary, Community Events, UCI MIND

The CHOC Children’s Neuroscience Institute and Alzheimer Biomarkers Consortium — Down Syndrome (ABC-DS) have teamed up to sponsor the 2022 Buddy Walk hosted by the Down Syndrome Association of Orange County (DSAOC). Funds raised for the walk support the programs and services DSAOC provides to their constituents. The event will be held on Sunday, Nov 6th starting at 11:00 am at the Santa Ana Zoo (admission included with registration)! In support of DSAOC, Eric Doran, MS, of UCI has created The CHOC/UCI Down Syndrome Program Team.  Please consider supporting this event by:  Joining our team (using the highlighted link or QR code above) Making a gift Sharing the event with…

The post 2022 Buddy Walk appeared first on UCI MIND.

Read More

First-Ever In-Person IMPACT-AD Course Held

By Commentary, Community Events, UCI MIND

The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD), is a comprehensive training program in clinical trials for Alzheimer’s disease and related dementias (ADRD). The course is directed by UCI MIND faculty member Joshua Grill and USC faculty member Dr. Rema Raman. Though in its third year, 2022 was the first time this innovative course could could be held in person and it was a resounding success. Throughout this past week, trainees from around the country, along with many of the nation’s best AD clinical trial investigators, stayed in La Jolla’s Estancia Hotel for an immersive, interactive, and comprehensive program. More than 100 investigators with…

The post First-Ever In-Person IMPACT-AD Course Held appeared first on UCI MIND.

Read More
English